Advertisement
Medtronic
Subscribe to Medtronic
View Sample

FREE Email Newsletter

Medtronic, Boston Scientific tout new centers overseas

September 17, 2013 2:24 pm | by Mass Device | News | Comments

Medical device titans Medtronic and Boston Scientific cut the ribbon on new facilities overseas this week, looking to develop new technologies that cater to markets in Ireland and China. Minnesota-based Medtronic announced a new $10-million-dollar "brainstorming" center at its Galway, Ireland campus...

Appeals court upholds Medtronic win over Gore in stent graft suit

September 12, 2013 1:42 pm | by Mass Device | News | Comments

A federal appeals court upheld a lower court's decision to toss a lawsuit filed in 2010 accusing Medtronic of violating patents held by W.L. Gore & Associates covering stent graft manufacturing techniques. Judge Mark Davis of the U.S. District Court for Eastern Virginia dismissed Gore's claims last year, saying the ruling made Medtronic's counterclaims moot.

El Camino Hospital Enrolls Second Patient in Global Clinical Trial Evaluating the Medtronic CoreValve® System in Intermediate Risk Patients with Aortic Valve Disease

September 11, 2013 3:38 pm | by Business Wire | News | Comments

El Camino Hospital, in partnership with the Taft Center for Clinical Research and the Fogarty Clinical Research Institute, both a part of the Fogarty Institute for Innovation, announced today that it has enrolled its second patient in a global clinical trial comparing the Medtronic CoreValve® System with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk for open-heart surgery.

Advertisement

Medtronic traces surgical kit possibly contaminated with fatal brain disease

September 6, 2013 12:02 pm | by Mass Device | News | Comments

Medtronic is working with New England hospitals and government health officials to track the movement of surgical medical equipment involved in several cases of possible patient exposure to Creutzfeldt-Jakob disease, a rare and fatal relative to the more commonly known "mad cow" disease.

Medtronic opens doors on innovation center in Singapore

September 5, 2013 8:59 am | by Mass Device | News | Comments

Medtech titan Medtronic opened the doors on a new Center of Excellence in Singapore, where new business models will be designed, tested and scaled for Asian markets. Based in Medtronic's existing Singapore facility, the new center will also develop commercial models that may eventually extend to various markets around the globe after passing muster in a single country.

ESC 2013: Medtronic's Symplicity hypertension treatment still promising at 1 and 3 years

September 3, 2013 2:27 pm | by Mass Device | News | Comments

New data on Medtronic's Symplicity renal denervation system showed the device is safe and effective at 1 and 3 years, the company announced this week. A pair of analyses released during the the European Society of Cardiology Congress in Amsterdam this week showed positive results for the hypertension treatment system.

Medtronic Announces Formation of Hospital Solutions Business Aimed at Driving Efficiencies and Cost Savings

September 2, 2013 12:06 pm | by The Associated Press | News | Comments

Medtronic, Inc. (NYSE: MDT) today announced the formation of Medtronic Hospital Solutions, a new business focused on developing novel partnerships with hospitals to provide services directly related to hospital operational efficiency. The new business will focus initially on offering services in Europe...

Medtronic's maneuvers may signal long-term struggles for industry

August 28, 2013 12:51 pm | by Mass Device | News | Comments

When Medtronic announced that it paid $200 million in cash for chronic disease management firm Cardiocom the medical device giant said the acquisition was indicative of a broader vision for the company's future, but Wall Street analysts are warning that it may also suggest "challenging times ahead" for the device industry.

Advertisement

Medtronic hands Pioneer Plus catheters to Volcano in closed-doors deal

August 27, 2013 12:40 pm | by Mass Device | News | Comments

Medical device giant Medtronic is handing its Pioneer Plus re-entry catheter product line over to Volcano for an undisclosed amount, the companies announced this week. The deal, which Volcano hopes will help it expand its reach in peripheral indications, is expected to close this month and is structured as an "asset purchase."

Another lawsuit against Medtronic's Infuse proceeds in Arizona

August 27, 2013 8:59 am | by Mass Device | News | Comments

Another patient injury lawsuit is set to proceed against Medtronic and it's problematic Infuse bone-growth protein after an Arizona district judge ruled that federal preemption doesn't apply in a case accusing the company of off-label marketing, a relatively new tactic that is proving somewhat successful for patients waging battles against medical device makers.

Volcano Corporation Announces Execution Of Agreement To Purchase Pioneer PlusT Re-Entry Catheter Product Line From Medtronic

August 26, 2013 4:05 pm | by The Associated Press | News | Comments

Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has signed an agreement to acquire the Pioneer PlusT diagnostic ultrasound ...

German ban on Medtronic TAVI begins today, Edwards makes room for 'compassionate cases'

August 26, 2013 3:50 pm | by Mass Device | News | Comments

Starting today, medical device giant Medtronic is banned from selling its CoreValve and CoreValve Evolut transcatheter aortic valve implantation systems in Germany, thanks to a court ruling in favor of rival device maker Edwards Lifesciences.  

Fed Rejects Medtronic's Preemption Claim In Off-Label Use of Device

August 23, 2013 4:47 pm | by Business Wire | News | Comments

Kent L. Klaudt, lawyer at the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that U.S. District Court Judge G. Murray Snow of the District of Arizona denied in large part Medtronic’s motion to dismiss a personal injury lawsuit brought by Dr. Cristina Ramirez against the company on grounds that the claims are preempted by Federal law.

Advertisement

Medtronic dips on missed Q1 revenues

August 20, 2013 10:19 am | by Mass Device | News | Comments

Investors pushed shares of Medtronic down this morning after the world's largest pure-play medical device company reported mixed results for its fiscal 1st quarter. Fridley, Minn.-based Medtronic posted profits of $953 million, or 93¢ per share, on sales of $4.08 billion for the 3 months ended July 26.

GPOs: Medtronic, St. Jude, Boston Scientific land new deals from Premier

August 13, 2013 12:27 pm | by Mass Device | News | Comments

Premier Healthcare Alliance awarded several new contracts for drug-eluting stents, traditional stents and other intervention products to 8 heavy hitters in the cardiology space. Abbott, Boston Scientific, and Medtronic all landed supplier deals for drug-eluting and traditional stents.

Medtronic Completes $200M Deal for Cardiocom

August 13, 2013 10:02 am | by The Associated Press | News | Comments

Medtronic Inc. said Monday that it closed its $200 million acquisition of Cardiocom, which develops and provides services that help manage chronic diseases. The Minneapolis-based medical device maker said it doesn't expect the deal to affect its fiscal year 2014 profit.

Deep Brain Stimulation System Is First to Sense and Record Brain Activity While Delivering Therapy

August 12, 2013 11:27 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the first implant of a novel deep brain stimulation (DBS) system that, for the first time, enables the sensing and recording of select brain activity while simultaneously providing targeted DBS therapy. This initiates research on how the brain responds to the therapy...

New Implantable Device Can Manipulate and Record Brain Activity

August 9, 2013 3:00 pm | by Massachusetts Institute of Technology | News | Comments

A new brain implant that can record neural activity while it simultaneously delivers electric current has been implanted into a patient for the first time. The new device from Medtronic, a Minneapolis-based medical device company, can also adjust its electrical output in response to the changing conditions of the brain.

Conflicting decisions and new tactics in Medtronic Infuse lawsuits

August 8, 2013 1:06 pm | by Mass Device | News | Comments

The battle over Medtronic's Infuse bone-growth protein continues to be a roller-coaster, with judges in 2 states issuing seemingly conflicting rulings about the validity of patient injury lawsuits against the Minnesota medical device giant and its troubled Infuse bone-growth protein.

Medtronic Provides Grant for Program Focused on Medical Devices for Developing Countries

July 24, 2013 10:48 am | by Johns Hopkins University | News | Comments

Medtronic, one of the world’s largest medical technology companies, has entered into an innovative partnership with The Johns Hopkins University, agreeing to provide $200,000 a year for up to three years and skilled mentoring to help biomedical engineering students design new healthcare solutions for underserved patients in developing countries.

Edwards Lifesciences goes after another set of Medtronic patents

July 16, 2013 1:35 pm | by Mass Device | News | Comments

Edwards Lifesciences wants a federal judge to rule that a pair of patents owned by arch-rival Medtronic are invalid because they aren't specific enough. The patents cover nerve stimulation technology. Edwards and Medtronic have spent considerable time in courts around the world, each arguing that the other's transcatheter aortic valve implant infringes various patents.

Medtronic's insulin pump recall gets FDA's highest-risk label

July 15, 2013 9:59 am | by Mass Device | News | Comments

The FDA put its highest-risk label, Class I, on a recall of Medtronic's (NYSE:MDT) Paradigm insulin infusion pumps, which the medtech giant had warned about earlier this year. Medtronic Canada said last month that it received 2 reports on its Paradigm and Polyfin infusion devices, concerning the over- and under-delivery of insulin therapy.

Medtronic prevails in bone mill antitrust suit filed by Lenox MacLaren Surgical

July 3, 2013 11:21 am | by Mass Device | News | Comments

Medtronic (NYSE:MDT) prevailed in an antitrust lawsuit filed over a bone mill made by Lenox MacLaren Surgical, with a federal judge ruling that Lenox misrepresented the size of the bone mill market and failed to adequately market its own device.

More hospitals settle Medtronic's Kyphon Medicare fraud cases

July 2, 2013 12:58 pm | by Mass Device | News | Comments

Some 55 U.S. hospitals agreed to pay a total of $34 million to settle U.S. Justice Dept. charges that they overcharged Medicare for Medtronic's (NYSE:MDT)'s kyphoplasty spine procedure, acquired in the $3.9 billion buyout of Kyphon in 2007, the Justice Dept. said today.

Integra LifeSciences recall affects Medtronic's Infuse kits

July 2, 2013 12:53 pm | by Mass Device | News | Comments

Minnesota medical device giant Medtronic (NYSE:MDT) confirmed today that it recalled certain of its already-troubled Infuse spinal fusion surgery kits after learning of possible contamination in sponges manufactured by Integra Lifesciences.  

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading